332 related articles for article (PubMed ID: 25750061)
21. Pro-Dopamine Regulator (KB220) A Fifty Year Sojourn to Combat Reward Deficiency Syndrome (RDS): Evidence Based Bibliography (Annotated).
Kenneth B; Edward MJ; Marjorie GLC; David B; Bruce S; Panayotis TK; William DB; Davis S; Lisa L; Eric BR; Mark M; David M; Lyle F; Rajendra BD
CPQ Neurol Psychol; 2018; 1(2):. PubMed ID: 30957097
[TBL] [Abstract][Full Text] [Related]
22. Dopamine signaling in food addiction: role of dopamine D2 receptors.
Baik JH
BMB Rep; 2013 Nov; 46(11):519-26. PubMed ID: 24238362
[TBL] [Abstract][Full Text] [Related]
23. Neurogenetics and clinical evidence for the putative activation of the brain reward circuitry by a neuroadaptagen: proposing an addiction candidate gene panel map.
Chen TJ; Blum K; Chen AL; Bowirrat A; Downs WB; Madigan MA; Waite RL; Bailey JA; Kerner M; Yeldandi S; Majmundar N; Giordano J; Morse S; Miller D; Fornari F; Braverman ER
J Psychoactive Drugs; 2011; 43(2):108-27. PubMed ID: 21858957
[TBL] [Abstract][Full Text] [Related]
24. The addictive brain: all roads lead to dopamine.
Blum K; Chen AL; Giordano J; Borsten J; Chen TJ; Hauser M; Simpatico T; Femino J; Braverman ER; Barh D
J Psychoactive Drugs; 2012; 44(2):134-43. PubMed ID: 22880541
[TBL] [Abstract][Full Text] [Related]
25. Dopamine homeostasis: brain functional connectivity in reward deficiency syndrome.
Febo M; Blum K; Badgaiyan RD; Baron D; Thanos PK; Colon-Perez LM; Demortrovics Z; Gold MS
Front Biosci (Landmark Ed); 2017 Jan; 22(4):669-691. PubMed ID: 27814639
[TBL] [Abstract][Full Text] [Related]
26. A meta-analysis of the relationship between brain dopamine receptors and obesity: a matter of changes in behavior rather than food addiction?
Benton D; Young HA
Int J Obes (Lond); 2016 Mar; 40 Suppl 1(Suppl 1):S12-21. PubMed ID: 27001642
[TBL] [Abstract][Full Text] [Related]
27. Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions.
Blum K; Bowirrat A; Braverman ER; Baron D; Cadet JL; Kazmi S; Elman I; Thanos PK; Badgaiyan RD; Downs WB; Bagchi D; Llanos-Gomez L; Gold MS
Int J Environ Res Public Health; 2021 Nov; 18(21):. PubMed ID: 34770047
[TBL] [Abstract][Full Text] [Related]
28. rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts.
Blum K; Liu Y; Wang W; Wang Y; Zhang Y; Oscar-Berman M; Smolen A; Febo M; Han D; Simpatico T; Cronjé FJ; Demetrovics Z; Gold MS
Postgrad Med; 2015 Mar; 127(2):232-41. PubMed ID: 25526228
[TBL] [Abstract][Full Text] [Related]
29. Reward circuitry dopaminergic activation regulates food and drug craving behavior.
Blum K; Liu Y; Shriner R; Gold MS
Curr Pharm Des; 2011; 17(12):1158-67. PubMed ID: 21492092
[TBL] [Abstract][Full Text] [Related]
30. Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome: Dopaminergic Key to Homeostasis and Neuroplasticity.
Blum K; Febo M; Badgaiyan RD; Braverman ER; Dushaj K; Li M; Demetrovics Z
Curr Pharm Des; 2016; 22(38):5837-5854. PubMed ID: 27510492
[TBL] [Abstract][Full Text] [Related]
31. Molecular role of dopamine in anhedonia linked to reward deficiency syndrome (RDS) and anti- reward systems.
Gold MS; Blum K; Febo M; Baron D; Modestino EJ; Elman I; Badgaiyan RD
Front Biosci (Schol Ed); 2018 Mar; 10(2):309-325. PubMed ID: 29293435
[TBL] [Abstract][Full Text] [Related]
32. Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the Promised Land?
Blum K; Thanos PK; Badgaiyan RD; Febo M; Oscar-Berman M; Fratantonio J; Demotrovics Z; Gold MS
Expert Opin Biol Ther; 2015 Jul; 15(7):973-85. PubMed ID: 25974314
[TBL] [Abstract][Full Text] [Related]
33. The influence of drug class on reward in substance use disorders.
Jones JD; Arout CA; Luba R; Murugesan D; Madera G; Gorsuch L; Schusterman R; Martinez S
Pharmacol Biochem Behav; 2024 Jul; 240():173771. PubMed ID: 38670466
[TBL] [Abstract][Full Text] [Related]
34. Neural reward processing under dopamine agonists: imaging.
Kassubek J; Abler B; Pinkhardt EH
J Neurol Sci; 2011 Nov; 310(1-2):36-9. PubMed ID: 21762926
[TBL] [Abstract][Full Text] [Related]
35. Imaging gene-substance interactions: the effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward.
Kirsch P; Reuter M; Mier D; Lonsdorf T; Stark R; Gallhofer B; Vaitl D; Hennig J
Neurosci Lett; 2006 Sep; 405(3):196-201. PubMed ID: 16901644
[TBL] [Abstract][Full Text] [Related]
36. Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome?
Gold MS; Baron D; Bowirrat A; Blum K
J Neurol Sci; 2020 Nov; 418():117137. PubMed ID: 32957037
[TBL] [Abstract][Full Text] [Related]
37. Imaging genetics and the neurobiological basis of individual differences in vulnerability to addiction.
Sweitzer MM; Donny EC; Hariri AR
Drug Alcohol Depend; 2012 Jun; 123 Suppl 1():S59-71. PubMed ID: 22342427
[TBL] [Abstract][Full Text] [Related]
38. Dopamine and glucose, obesity, and reward deficiency syndrome.
Blum K; Thanos PK; Gold MS
Front Psychol; 2014; 5():919. PubMed ID: 25278909
[TBL] [Abstract][Full Text] [Related]
39. Molecular Genetic Testing in Reward Deficiency Syndrome (RDS): Facts and Fiction.
Blum K; Badgaiyan RD; Agan G; Fratantonio J; Simpatico T; Febo M; Haberstick BC; Smolen A; Gold MS
J Reward Defic Syndr; 2015; 1(1):65-68. PubMed ID: 26052557
[TBL] [Abstract][Full Text] [Related]
40. Genotrim, a DNA-customized nutrigenomic product, targets genetic factors of obesity: hypothesizing a dopamine-glucose correlation demonstrating reward deficiency syndrome (RDS).
Blum K; Chen TJ; Meshkin B; Downs BW; Gordon CA; Blum S; Mangucci JF; Braverman ER; Arcuri V; Deutsch R; Pons MM
Med Hypotheses; 2007; 68(4):844-52. PubMed ID: 17071010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
